A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2004
12/01/2004	CN1177583C Formulations for parenteral use of estramustine phosphate with improved pharmacological properties
12/01/2004	CN1177582C Pharmaceutical aerosol compsn. contg. HFA227 and HFA 134a
11/2004
11/30/2004	US6825355 For therapy of immunologic disorders such as transplant rejection, rheumatoid arthritis. multiple sclerosis, inflammatory bowel disease, lupus, graft vs. host disease
11/30/2004	US6825349 Purine derivatives for treatment of gastrointestinal disorders, immunological disorders, neurological disorders
11/30/2004	US6825231 Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them
11/30/2004	US6825224 Prodrugs of carbamate inhibitors of IMPDH
11/30/2004	US6825219 Substituted benzimidazole compounds
11/30/2004	US6825207 Anticancer agents
11/30/2004	US6825200 Substituted dipeptides having nos inhibiting activity
11/30/2004	US6825197 Cyclic GMP-specific phosphodiesterase inhibitors
11/30/2004	US6825190 Protein kinase inhibitors and uses thereof
11/30/2004	US6825189 Treating withdrawal symptoms caused by smoking cessation
11/30/2004	US6825185 Improving the cardiovascular profile of a cox-2 selective inhibitor by administering with 3-hydroxy-3- methylglutaryl coenzyme a, an antiplatelet agent, a thrombin inhibitor or a thromboxane inhibitor
11/30/2004	US6825184 For use as anti-inflammatory agents
11/30/2004	US6825180 Cytokine intracellular signaling inhibitors; antiinflammatory agents
11/30/2004	US6824978 Regulation of endogenous gene expression in cells using zinc finger proteins
11/30/2004	US6824790 Capsule, tablet with enteric, protective coatings; bioavailability
11/30/2004	CA2298245C Matrix controlled release device
11/30/2004	CA2245142C New phenanthridines
11/25/2004	WO2004101775A1 Novel stem cell derived from adult tissue and use thereof
11/25/2004	WO2004101595A1 Estratriene derivatives
11/25/2004	WO2004101551A1 Crystal of benzimidazole derivative and process for producing the same
11/25/2004	WO2004101529A1 Nitrogenous heterocyclic compound and medical use thereof
11/25/2004	WO2004101526A1 Polymorphous crystal of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-qunolinecarboxamide and method for preparation thereof
11/25/2004	WO2004101525A1 Crystalline form of aryl aniline beta-2 adrenergic receptor agonist
11/25/2004	WO2004100989A1 Preventives/remedies for snore or respiratory disturbances during sleep
11/25/2004	WO2004100982A1 C1 inhibitor with short half-life for transient treatment
11/25/2004	WO2004100972A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	WO2004100863A2 Composition for preventing and treatment of asthma comprising alpha-lipoic acid as an effective component
11/25/2004	WO2004087200A3 Vaccine and serum for protection of cystic fibrosis patients against pseudomonas aeruginosa
11/25/2004	US20040236147 Integrin antagonist; antiinflammatory agents; antiarthritic agents; inflammatory bowel disease; lupus; multiple sclerosis; asthma; psoriasis;antidiabetic agents; cardiovascular disorders
11/25/2004	US20040236108 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO); treat an inflammatory disease or condition, related to carbohydrate metabolism, smooth muscle cell function; chemical synthesis
11/25/2004	US20040236104 Substituted 4-aminocyclohexanols
11/25/2004	US20040236087 Moraxella(branhamella) catarrhalis antigens
11/25/2004	US20040235930 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
11/25/2004	US20040235921 6-substituted 2,3-dihydro-1,4-benzodioxine, 2-position substituted with carboxy, or (C1 C6)alkoxycarbonyl; diabetes, obesity; 6-[2-(R)-[2-(S)-hydroxy-3-(4-hydroxy-3-methanesulfonamido-phenoxy)propylamino]propyl]-2,3-dihydro-1,4-benzodioxine-2-(R)-carboxylic acid; B3 andrenergic receptor agonist
11/25/2004	US20040235919 Useful in treating cell proliferative disorders associated with an altered cell cycle dependent kinase activity; cancer, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders
11/25/2004	US20040235896 Certain azacycloalkyl substituted acetic acid derivatives
11/25/2004	US20040235894 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of asthma and/or rhinitis; respiratory system disorders
11/25/2004	US20040235890 Remedies for allergic diseases
11/25/2004	US20040235887 Carbamates derived from arylalkylamines
11/25/2004	US20040235885 Novel composition and method for stabilizing the same
11/25/2004	US20040235873 foods and drinks, animal feeds or adjuvants comprising orotic acid and/or salts, used as antiallergens
11/25/2004	US20040235864 Jun kinase inhibitors
11/25/2004	US20040235863 As stimulators for soluble guanylate cyclase and to their use as agents in the therapy of cardiovascular diseases, hypertonicity, thrombo-embolic diseases and ischemia, sexual dysfunction or inflammations and for the treatment of diseases of the central nervous system
11/25/2004	US20040235862 Protein kinase inhibitors
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235858 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
11/25/2004	US20040235854 1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity
11/25/2004	US20040235849 For therapy and prophylaxis of states of pain
11/25/2004	US20040235848 Phenylalanine derivatives
11/25/2004	US20040235838 Use of 2-alkoxyphenol-substituted imidazotriazinones
11/25/2004	US20040235833 5-[(2R)-2-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl) phenyl]ethyl}amino) propyl]-N-(2-methoxybenzyl)-1H-indole-2-carboxamide for example; asthma, bronchitis, and emphysema; beta-2 adrenergic receptor agonists
11/25/2004	US20040235825 Administering compounds such as N-[4-[2-[2-(1-naphthyl)propanoylamino]phenyl]butanoyl]-(3,5-dimethylisoxazol-4-yl)sulfonamide for prophylaxis and therapy of pain, allodynia, hyperalgesia, pruritus, urticaria, atopic dermatitis, contact dermatitis, allergic conjunctivitis, asthma, rhinitis, sneeze
11/25/2004	US20040235816 Administering compounds such as 1-benzhydryl-3-[(methylsulfonyl)(phenyl)methylene]azetidine for therapy of schizophrenia, Parkinson's disease, and Alzeimer's disease
11/25/2004	US20040235807 Administering formulation for intranasal drug administration, wherein the formulation comprises: a topically administrable decongestant;a topically administrable corticosteroid: and carrier that is suitable for nasal drug administration
11/25/2004	US20040235794 Remedies for respiratory diseases comprising sphingosine-1-phosphate receptor controller
11/25/2004	US20040235786 Highly purified antiendotoxin compound
11/25/2004	US20040235726 Glucagon-like peptides (glp-1) and treatment of respiratory distress
11/25/2004	US20040235074 Methods for the treatment or prevention of immune disorders using anti-CD40 antibodies
11/25/2004	US20040234993 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
11/25/2004	US20040234631 Composition comprising soy and use thereof in the provention and/or treatment of various diseases
11/25/2004	US20040234614 Chitin microparticles and their medical uses
11/25/2004	US20040234522 therapy, diagnosis of immunology diseases; response to antigenic stimulants; cell differentiation of lymphocytes
11/25/2004	US20040232205 Lantibiotic
11/25/2004	US20040231666 Adsorbents and uses thereof
11/25/2004	DE10319109A1 Antitussive agent for relieving, preventing or treating cough comprises cynanchi atrati radix extract and carrier or excipient
11/25/2004	CA2526025A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	CA2525909A1 Novel stem cell derived from adult tissue and use thereof
11/25/2004	CA2525651A1 Estratriene derivatives
11/25/2004	CA2525522A1 C1 inhibitor with short half-life for transient treatment
11/25/2004	CA2523978A1 Crystal of benzimidazole derivative and process for producing the same
11/24/2004	EP1479384A1 Fibrosis inhibitor
11/24/2004	EP1478762A2 Nucleic acid-associated proteins
11/24/2004	EP1478748A2 Fce fusion proteins for treatment of allergy and asthma
11/24/2004	EP1478741A1 Combination of a growth factor and a protease enzyme
11/24/2004	EP1478662A1 Method for producing hypoallergenic major birch pollen allergens rbet v 1
11/24/2004	EP1478648A2 Phosphorus-containing compounds uses thereof
11/24/2004	EP1478627A1 Method
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478620A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/24/2004	EP1478438A1 Methods and compositions for the treatment of asthma and related disorders
11/24/2004	EP1478399A1 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
11/24/2004	EP1478398A1 New medicinal compositions on the basis of anticholinergic agents and egfr kinase inhibitors
11/24/2004	EP1478396A1 Process for the preparation of a nutrient formulation
11/24/2004	EP1478394A2 Polypeptide formulation
11/24/2004	EP1478381A2 Use of soluble gamma delta t cell receptors for regulating t cell function
11/24/2004	EP1478378A2 Anti-allergic complex molecules
11/24/2004	EP1478371A2 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/24/2004	EP1478359A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
11/24/2004	EP1478358A1 Aryl ureas with angiogenesis inhibiting activity
11/24/2004	EP1478357A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
11/24/2004	EP1478354A2 Use of tgf-beta antagonists to treat or to prevent chronic transplant rejection
11/24/2004	EP1478342A1 Sterile filtered nanoparticule formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
11/24/2004	EP1478340A1 Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions
11/24/2004	EP1478236A2 Targeted retrograde gene delivery to motor neurons
11/24/2004	EP1272201B1 Use of compatible solutes as substances having free radical scavenging properties
11/24/2004	EP1175214B1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
11/24/2004	EP1146883A4 Modulation of immune response by ribavirin
11/24/2004	EP1100465B1 Medicinal aerosol formulations

1 ... 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 ... 878